During the Veeva R&D and Quality Summit held in Madrid last month, web editor Nicole Raleigh sat down with Chris Moore, president of Europe for Veeva Systems, to discuss the event and i
As part of the UK's recent Spring Budget announcement, the UK Chancellor, Jeremy Hunt, announced a £3.4 billion fully funded NHS productivity plan to enhance NHS services through digital to
Back at Veeva Commercial Summit in Madrid in November, web editor Nicole Raleigh had a chance to sit down with Veeva Systems’ President Europe, Chris Moore, and have an in-depth conversatio
Sarepta Therapeutics has decided not to continue the development of vesleteplirsen, a follow-up to its Duchenne muscular dystrophy (DMD) therapy Exondys 51.
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.